Backed by Coca-Cola and Arcor to invest in digital transformation for the consumer value chain.
About Kamay Ventures
Kamay Ventures is a Buenos Aires-based corporate venture capital fund backed jointly by Coca-Cola and Arcor, two of the largest consumer-products operators in Latin America. The fund writes seed checks in the $250K to $1M range and focuses on digital transformation across the consumer value chain, with healthcare interest concentrated in wellness and consumer health rather than clinical or AI-native plays. Because Kamay is a strategic CVC tied to two major beverage and snack companies, the investment logic is concentrated on opportunities that connect to the parents’ supply chains, retail distribution, consumer-data infrastructure, or brand portfolios. For healthcare and wellness founders, that means the fit is real for businesses building health-adjacent consumer brands, distribution-tech, or digital products that integrate with FMCG channels, and the fit is poor for B2B clinical software or research-stage therapeutics. The geographic focus is Latin America, with Coca-Cola’s and Arcor’s operating reach giving Kamay a regional sourcing and partnership advantage. The right founder profile is a consumer wellness or digital health brand with credible early traction, a defensible product proposition, and a clear thesis on how distribution through Coca-Cola or Arcor channels accelerates scale. The wrong fit is a clinical AI startup, a medical device, or any business where the FMCG channel is irrelevant. The right entry path is through Buenos Aires and Sao Paulo founder networks, through corporate-development teams at Coca-Cola Latin America and Arcor, and through warm introductions from co-investors at firms like Globant Ventures, NXTP, and Cygnus. When pitching, lead with the strategic fit to Coca-Cola or Arcor distribution and quantify what that partnership unlocks, then connect to standalone unit economics and brand defensibility. Avoid pitching Kamay as a generic seed check; the strategic angle is the differentiator. Caveats: as with any CVC, founders should manage strategic exclusivity terms carefully and think about how dependent they want to be on a single corporate partner, particularly when that partner has competitors who could be future customers or acquirers. Use Kamay when the FMCG channel is a genuine accelerator for your wellness or consumer health business, not as a default Latin American seed check.
Founder reviews
Other portfolio companies
Companies in Kamay Ventures's portfolio not currently in our directory.
- Auravant
- Wiagro
- Zippin
- Kilimo
- Webee
Team
Pitch / review this investor
Have you raised from Kamay Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).